Clinical Trial Update: Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 dose-escalation trial evaluating neoadjuvant radiosurgery for metastatic brain tumors; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Brain Metastases | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING